rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Brooke Story

Director

Company insider

Files Form 4 as: Director, LivaNova; Director, PolyPid; Director, Sigilon Therapeutics.

In numbers

Trades disclosed
28
Buys
0
Sells
2
Bought
$0
Sold
$388K
Companies
3
Companies where not an officer
3
First trade
14 Jun 2021
Last trade
4 Sep 2026
Last filed
8 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
LIVN LivaNovaDirector · Medical Devices · last 4 Sep 20260 buys · 2 sells
PYPD PolyPidDirector · Medical Devices · last 15 Jul 20260 buys · 0 sells
Sigilon TherapeuticsDirector · last 26 May 20220 buys · 0 sells

Activity over time

1 Nov 2025 – 1 Oct 2026
10Nov 25Feb 26May 26Jul 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
4 Sep 2026filed 8 Sep 2026LIVN LivaNovaMedical DevicesSEC FORM 4 Sold$187K2,300 at $81.42filing
4 Sep 2026filed 8 Sep 2026LIVN LivaNovaMedical DevicesSEC FORM 4 Sold$187K2,300 at $81.42filing
15 Jul 2026filed 17 Jul 2026PYPD PolyPidoption or derivative · Medical DevicesSEC FORM 4 Code A$41K9,132 at $4.46filing
15 Jul 2026filed 17 Jul 2026PYPD PolyPidoption or derivative · Medical DevicesSEC FORM 4 Code A$41K9,132 at $4.46filing
15 Jun 2026filed 17 Jun 2026LIVN LivaNovaMedical DevicesSEC FORM 4 Code M—4,042 at $0.00filing
15 Jun 2026filed 17 Jun 2026LIVN LivaNovaMedical DevicesSEC FORM 4 Code F$39K486 at $79.70filing
15 Jun 2026filed 17 Jun 2026LIVN LivaNovaoption or derivative · Medical DevicesSEC FORM 4 Code M—4,042 at $0.00filing
15 Jun 2026filed 17 Jun 2026LIVN LivaNovaoption or derivative · Medical DevicesSEC FORM 4 Code M—4,042 at $0.00filing
15 Jun 2026filed 17 Jun 2026LIVN LivaNovaoption or derivative · Medical DevicesSEC FORM 4 Code A—2,383 at $0.00filing
15 Jun 2026filed 17 Jun 2026LIVN LivaNovaoption or derivative · Medical DevicesSEC FORM 4 Code A—2,383 at $0.00filing
15 Jun 2026filed 17 Jun 2026LIVN LivaNovaMedical DevicesSEC FORM 4 Code M—4,042 at $0.00filing
15 Jun 2026filed 17 Jun 2026LIVN LivaNovaMedical DevicesSEC FORM 4 Code F$39K486 at $79.70filing
18 Nov 2025filed 19 Nov 2025LIVN LivaNovaMedical DevicesSEC FORM 4 Sold$13K250 at $53.94filing
15 Jun 2025filed 17 Jun 2025LIVN LivaNovaoption or derivative · Medical DevicesSEC FORM 4 Code M—3,416 at $0.00filing
15 Jun 2025filed 17 Jun 2025LIVN LivaNovaoption or derivative · Medical DevicesSEC FORM 4 Code A—4,042 at $0.00filing
15 Jun 2025filed 17 Jun 2025LIVN LivaNovaMedical DevicesSEC FORM 4 Code M—3,416 at $0.00filing
15 Jun 2025filed 17 Jun 2025LIVN LivaNovaMedical DevicesSEC FORM 4 Code F$19K410 at $45.76filing
15 Jun 2024filed 18 Jun 2024LIVN LivaNovaoption or derivative · Medical DevicesSEC FORM 4 Code M—2,680 at $0.00filing
15 Jun 2024filed 18 Jun 2024LIVN LivaNovaoption or derivative · Medical DevicesSEC FORM 4 Code A—3,416 at $0.00filing
15 Jun 2024filed 18 Jun 2024LIVN LivaNovaMedical DevicesSEC FORM 4 Code M—2,680 at $0.00filing

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Anne M. LiddyChief Legal Officer · Chief Legal Officer at LivaNova, filing Form 4 there in the last year
Francesco BianchiDirector · Director at LivaNova, filing Form 4 there in the last year
Ahmet TezelChief Innovation Officer · Chief Innovation Officer at LivaNova, filing Form 4 there in the last year
Dikla Czaczkes AkselbradChief Executive Officer · Chief Executive Officer at PolyPid, filing Form 4 there in the last year
Dalit Fellous HazanDeputy CEO, EVP, RD, CRA · Deputy CEO, EVP, RD, CRA at PolyPid, filing Form 4 there in the last year